Efficacy and safety of Xileisan combined with mesalazine for ulcerative colitis: A meta-analysis and trial sequential analysis

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 21

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Clin Cases. Jul 26, 2024; 12(21): 4703-4716
Published online Jul 26, 2024. doi: 10.12998/wjcc.v12.i21.4703

Full Size Figure Download Figure

Figure 1 Literature screening flowchart.

Citation: Yang XY, Yu YF, Tong KK, Hu G, Yu R, Su LJ. Efficacy and safety of Xileisan combined with mesalazine for ulcerative colitis: A meta-analysis and trial sequential analysis. World J Clin Cases 2024; 12(21): 4703-4716
URL: https://www.wjgnet.com/2307-8960/full/v12/i21/4703.htm
DOI: https://dx.doi.org/10.12998/wjcc.v12.i21.4703

Yang XY, Yu YF, Tong KK, Hu G, Yu R, Su LJ. Efficacy and safety of Xileisan combined with mesalazine for ulcerative colitis: A meta-analysis and trial sequential analysis. World J Clin Cases 2024; 12(21): 4703-4716 [PMID: 39070843 DOI: 10.12998/wjcc.v12.i21.4703]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.